Evaluating the Safety, Tolerability, Pharmacokinetics and Receptor Occupancy of BMS-984923
Clinical trial NCT04805983 · COMPLETED
Trial details
- NCT number
- NCT04805983
- Sponsor
- Yale University
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-25
- Primary completion
- 2022-04-24
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.